Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Terns Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +3 vs. Q3 2021
- Shares held
- 16.5M
- −221.7K (−1.3%) vs. Q3 2021
- Total value
- $116.7M
- −$57.6M (−33.1%) vs. Q3 2021
- New holders
- 6
- 16 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 3,791,204 | $26.8M | 0.35% | 00.0% | Unchanged |
| FMR LLC | 2,800,985 | $19.8M | 0.00% | −132,177−4.5% | Reduced |
| Vivo Capital, LLC | 2,675,133 | $18.9M | 1.14% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,345,959 | $16.6M | 0.35% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 1,238,800 | $8.76M | 0.17% | +113,064+10.0% | Added |
| Antara Capital LP | 949,834 | $6.71M | 0.65% | +175,000+22.6% | Added |
| BlackRock Inc. | 745,535 | $5.27M | 0.00% | +142,979+23.7% | Added |
| Vanguard Group Inc | 558,327 | $3.95M | 0.00% | +117,655+26.7% | Added |
| Samsara BioCapital, LLC | 289,068 | $2.04M | 0.41% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 180,935 | $1.28M | 0.00% | −12,401−6.4% | Reduced |
| State Street Corp | 162,019 | $1.15M | 0.00% | +11,679+7.8% | Added |
| Northern Trust Corp | 112,036 | $792.0K | 0.00% | −4,880−4.2% | Reduced |
| Bridgeway Capital Management, LLC | 95,500 | $675.0K | 0.01% | +95,500 | New |
| Morgan Stanley | 89,456 | $632.0K | 0.00% | +63,412+243.5% | Added |
| Caas Capital Management LP | 85,851 | $607.0K | 0.06% | 00.0% | Unchanged |
| Cowen and Company, LLC | 85,000 | $601.0K | 0.06% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 55,222 | $390.0K | 0.00% | −32,312−36.9% | Reduced |
| Millennium Management LLC | 53,281 | $377.0K | 0.00% | +53,281 | New |
| Bank of New York Mellon Corp | 35,700 | $253.0K | 0.00% | +8,187+29.8% | Added |
| Charles Schwab Investment Management Inc | 28,746 | $204.0K | 0.00% | −2,797−8.9% | Reduced |
| Marquette Asset Management, LLC | 16,619 | $117.0K | 0.02% | +16,619 | New |
| Goldman Sachs Group Inc | 15,208 | $108.0K | 0.00% | +15,208 | New |
| Parametric Portfolio Associates LLC | 12,317 | $87.0K | 0.00% | +12,317 | New |
| Nuveen Asset Management, LLC | 14,237 | $83.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 8,911 | $63.0K | 0.00% | +440+5.2% | Added |
| Bank of America Corp | 8,585 | $61.0K | 0.00% | +3,453+67.3% | Added |
| California State Teachers Retirement System | 8,160 | $58.0K | 0.00% | +3,521+75.9% | Added |
| American International Group, Inc. | 7,289 | $52.0K | 0.00% | −218−2.9% | Reduced |
| JPMorgan Chase & Co | 7,444 | $52.0K | 0.00% | +2,190+41.7% | Added |
| New York State Common Retirement Fund | 5,918 | $42.0K | 0.00% | +44+0.7% | Added |
| Wells Fargo & Company | 5,479 | $39.0K | 0.00% | +5,464+36,426.7% | Added |
| Citigroup Inc | 4,286 | $30.0K | 0.00% | +2,694+169.2% | Added |
| UBS Group AG | 3,775 | $27.0K | 0.00% | +3,775 | New |
| Royal Bank of Canada | 3,074 | $22.0K | 0.00% | +1,323+75.6% | Added |
| Tower Research Capital LLC (TRC) | 1,543 | $11.0K | 0.00% | +784+103.3% | Added |
| Legal & General Group Plc | 1,279 | $9.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 708 | $5.00K | 0.00% | 00.0% | Unchanged |
| Matthews International Capital Management LLC | 0 | $0 | 0.00% | −875,068−100.0% | Sold out |
| S&T Bank | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −400−100.0% | Sold out |